<code id='9054FFCED9'></code><style id='9054FFCED9'></style>
    • <acronym id='9054FFCED9'></acronym>
      <center id='9054FFCED9'><center id='9054FFCED9'><tfoot id='9054FFCED9'></tfoot></center><abbr id='9054FFCED9'><dir id='9054FFCED9'><tfoot id='9054FFCED9'></tfoot><noframes id='9054FFCED9'>

    • <optgroup id='9054FFCED9'><strike id='9054FFCED9'><sup id='9054FFCED9'></sup></strike><code id='9054FFCED9'></code></optgroup>
        1. <b id='9054FFCED9'><label id='9054FFCED9'><select id='9054FFCED9'><dt id='9054FFCED9'><span id='9054FFCED9'></span></dt></select></label></b><u id='9054FFCED9'></u>
          <i id='9054FFCED9'><strike id='9054FFCED9'><tt id='9054FFCED9'><pre id='9054FFCED9'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:knowledge    Page View:2151
          Paul Berggreen, a gastroenterologist at Arizona Digestive Health who formed a new lobbying group for independent physician practices. Arizona Digestive Health/ GI Alliance

          Private equity gets a bad rap in health care. But some doctors see that kind of cash and consolidation as the only way for their practices to survive — and now, they’re taking that message to Washington.

          Lower pay, difficult negotiations with insurance companies, regulatory requirements from both government and commercial payers, expensive and inefficient IT systems, and the challenge of competing against hospital systems have created a “cascade of problems that seem like they are almost insurmountable” for independent practices, said Paul Berggreen, a gastroenterologist at Arizona Digestive Health.

          advertisement

          Berggreen is joining with other doctors to start a lobbying group for private practices, the brand-new American Independent Medical Practice Association, or AIMPA, to fight against those problems and advocate for private practice physicians.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff
          Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

          AdobeRingTherapeutics,agenetherapystartuplaunchedbyFlagshipPioneering,haslaidoffjustunder20%ofitssta

          read more
          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more

          Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

          RubyWallauforSTATWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechne